Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Interna Technologies B.V.
Headquarters: Nijmegen, Netherlands
Website: http://www.interna-technolo...
Year Founded: 2006
Status: Private
BioCentury | Mar 24, 2022
Data Byte
Bringing gene knockdown to cancer treatment
A dozen candidates built on four gene silencing approaches have entered the clinic
BioCentury | Feb 13, 2021
Deals
Feb. 12 Quick Takes: NexImmune, Decibel rise in NASDAQ debuts; plus Sagimet’s $80M crossover, Forbion launches VectorY, Aurora Science leads InteRNA round and a SPAC for Sharecare
Shares of NexImmune Inc. (NASDAQ:NEXI) and Decibel Therapeutics Inc. (NASDAQ:DBTX) traded higher Friday after the companies priced IPOs on NASDAQ Thursday night. Hearing and balance therapy
BioCentury | Nov 11, 2013
Company News
BioSpring, Dr. Reddy's, InteRNA Technologies, Quiet Therapeutics, Laboratory of Pharmacology and Toxicology (LPT) GmbH & Co. KG, VU University Medical Center ca
Items per page:
1 - 10 of 12